Topic

Astrazeneca

FTSE 100 held back by AstraZeneca trial setback

*

FTSE 100 held back by AstraZeneca trial setback

AstraZeneca sees stock market value slump by more than £20bn after drug setback

*

AstraZeneca sees stock market value slump by more than £20bn after drug setback

Stocks mixed as weak miners weigh in muted trade

*

Stocks mixed as weak miners weigh in muted trade

FTSE 100 rises as US jobs data eases Fed rate hike fears

*

FTSE 100 rises as US jobs data eases Fed rate hike fears

Women dying of breast cancer as life-extending drug remains blocked in England

*

Women dying of breast cancer as life-extending drug remains blocked in England

FTSE 100 closes lower as drugs firms GSK and AstraZeneca struggle

*

FTSE 100 closes lower as drugs firms GSK and AstraZeneca struggle

Shot in the arm for GSK and AstraZeneca from cancer drug sales

*

Shot in the arm for GSK and AstraZeneca from cancer drug sales

Large proportion of diabetics may have undiagnosed heart failure, study suggests

*

Large proportion of diabetics may have undiagnosed heart failure, study suggests

Companies House suspends filing service after glitch puts personal data at risk

*

Companies House suspends filing service after glitch puts personal data at risk

AstraZeneca boss Pascal Soriot nets £17.7m in pay and bonuses for 2025

*

AstraZeneca boss Pascal Soriot nets £17.7m in pay and bonuses for 2025

FTSE 100 Live: Barclays boss gets £15m pay packet, BP halts buybacks

*

FTSE 100 Live: Barclays boss gets £15m pay packet, BP halts buybacks

AstraZeneca profits jump by 40% amid strong demand for cancer drugs

*

AstraZeneca profits jump by 40% amid strong demand for cancer drugs

GSK posts higher profits but indicates sales growth to slow in 2026

*

GSK posts higher profits but indicates sales growth to slow in 2026

AstraZeneca shares launch on New York Stock Exchange

*

AstraZeneca shares launch on New York Stock Exchange

AstraZeneca secures tie-up with Chinese firm for weight loss drugs

*

AstraZeneca secures tie-up with Chinese firm for weight loss drugs

FTSE 100 hits new record high as New Year rally gains momentum

*

FTSE 100 hits new record high as New Year rally gains momentum

FTSE fails to sparkle in tame pre-holiday trade

*

FTSE fails to sparkle in tame pre-holiday trade

Boss of drugs giant GSK declares US best place to invest

*

Boss of drugs giant GSK declares US best place to invest

NHS services will not be cut to fund US pharma deal – Streeting

*

NHS services will not be cut to fund US pharma deal – Streeting

Zero-tariff deal with US to cost NHS £1 billion, No 10 says

*

Zero-tariff deal with US to cost NHS £1 billion, No 10 says

UK and US agree zero tariff deal on pharmaceuticals

*

UK and US agree zero tariff deal on pharmaceuticals

UK and US preparing to strike zero tariffs deal on pharmaceuticals

*

UK and US preparing to strike zero tariffs deal on pharmaceuticals

FTSE 100 slips amid Bank of England rate hold and fresh US falls

*

FTSE 100 slips amid Bank of England rate hold and fresh US falls

FTSE 100 closes higher as US markets rally after tech falls

*

FTSE 100 closes higher as US markets rally after tech falls

US ambassador warns pharma firms will quit UK if NHS does not pay more for drugs

*

US ambassador warns pharma firms will quit UK if NHS does not pay more for drugs

UK economy ‘bleeding out’ with brain drain in science and tech, peers warn

*

UK economy ‘bleeding out’ with brain drain in science and tech, peers warn

FTSE 100 hits another high despite concerns over US government shutdown

*

FTSE 100 hits another high despite concerns over US government shutdown

FTSE 100 Live: Index hits new record, AstraZeneca leads pharma rebound

*

FTSE 100 Live: Index hits new record, AstraZeneca leads pharma rebound

Convatec to open new R&D hub in Manchester as part of £500m UK investment

*

Convatec to open new R&D hub in Manchester as part of £500m UK investment

AstraZeneca to overhaul US listing but remain on London market and keep UK HQ

*

AstraZeneca to overhaul US listing but remain on London market and keep UK HQ